 |
인쇄하기
취소
|
Drug firms boosting R&D spending
Domestic pharmaceutical firms have been spending more on research and development (R&D) projects to strengthen their technology leadership, industry data showed recently.
According to the Korea Health Industry Development Institute data, the combined R&D spending of 52 local firms listed in Korean Stock Exchange stood at 976.8 billion won in 2011, up 17.8 percent from a year earlier.
Cell...
According to the Korea Health Industry Development Institute data, the combined R&D spending of 52 local firms listed in Korean Stock Exchange stood at 976.8 billion won in 2011, up 17.8 percent from a year earlier.
Cell...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.